Project #60: GPER, inflammation and diabetic kidney disease
Forecasted
This grant from Diabetes Research Connection supports research on how GPER affects inflammation and kidney disease in type 1 diabetes, aiming to uncover new mechanisms and therapeutic targets.
Funder: Diabetes Research Connection
Due Dates (Anticipated): July 2027 (application window opens & full application submission deadline, projected)
Funding Amounts: Up to $75,000 per project for one year; graduate students eligible up to $50,000, postdocs/assistant professors up to $75,000.
Summary: Supports early-career scientists conducting innovative research on the mechanisms and treatment of diabetic kidney disease in type 1 diabetes, with a focus on the GPER receptor.
Key Information: For U.S.-based early-career researchers only; significant NIH-funded PIs are ineligible.
Description
This grant opportunity, offered by the Diabetes Research Connection (DRC), supports early-career scientists investigating novel mechanisms and therapeutic targets for diabetic kidney disease in the context of type 1 diabetes. The current focus is on understanding the role of the G protein-coupled estrogen receptor (GPER) in kidney function and inflammation, with the ultimate goal of developing new strategies to prevent or slow the progression of diabetic kidney disease. Projects are expected to be innovative, discovery-stage, and relevant to the complications of type 1 diabetes.
